| Gender diversea (n = 10) | Cisgender (n = 453) | P-valueb |
---|---|---|---|
Age, years | 13.6 ± 1.5 | 15.6 ± 2.7 | 0.017 |
Race, n (%) | Â | Â | 0.270 |
 White or Caucasian | 5 (50.0) | 286 (63.1) |  |
 Asian or NHOPIc | 3 (30.0) | 38 (6.4) |  |
 Black or African American | 0 (0.0) | 14 (3.1) |  |
 Other | 2 (20.0) | 97 (21.4) |  |
 Unknown/Declined | 0 (0.0) | 18 (4.0) |  |
Ethnicity, n (%) | Â | Â | 1.000 |
 Hispanic | 2 (20.0) | 86 (19.0) |  |
 Non-Hispanic | 8 (80.0) | 341 (75.3) |  |
 Unknown/Declined | 0 (0.0) | 26 (5.7) |  |
BMI kg/m2 | 18.8 ± 2.9 | 17.8 ± 2.8 | 0.261 |
Percent median BMId | 97.1 ± 14.8 | 87.9 ± 13.7 | 0.037 |
Vital signs | Â | Â | Â |
 Pulse (beats per minute) nadir during hospitalization | 44 ± 8.8 | 46 ± 10.6 | 0.501 |
 Systolic pressure (mmHg) nadir during hospitalization | 84 ± 7.1 | 84 ± 9.7 | 0.995 |
 Diastolic pressure (mmHg) nadir during hospitalization | 46 ± 5.8 | 45 ± 7.3 | 0.884 |
Electrolyte analysis at admission | Â | Â | Â |
 Sodium (mmol/L) | 139 ± 1.6 | 138 ± 8.7 | 0.966 |
 Potassium (mmol/L) | 3.8 ± 0.3 | 3.9 ± 0.7 | 0.526 |
 Magnesium (mg/dL) | 2.1 ± 0.2 | 2.1 ± 0.2 | 0.882 |
 Phosphorous (mg/dL) | 3.9 ± 0.5 | 4.0 ± 2.1 | 0.892 |
Other laboratory evaluation at admission | Â | Â | Â |
 White blood cell count (× 109/L) | 5.4 ± 0.9 | 6.1 ± 1.8 | 0.222 |
 Hemoglobin (g/dL) | 12.8 ± 1.1 | 13.0 ± 1.2 | 0.698 |
 Hematocrit (%) | 38.0 ± 2.7 | 38.3 ± 3.2 | 0.776 |
 Thyroid stimulating hormone (mIU/L) | 1.5 ± 1.2 | 2.0 ± 1.4 | 0.274 |
 Free thyroxine (pmol/L) | 10.5 ± 3.5 | 12.0 ± 1.8 | 0.008 |
 Aspartate transaminase (U/L) | 25 ± 4.2 | 29 ± 35.4 | 0.725 |
 Alanine transaminase (U/L) | 20 ± 7.5 | 22 ± 29.1 | 0.849 |
 Triglycerides (mg/dL) | 25 ± 19.8 | 47 ± 33.3 | 0.111 |
 Cholesterol (mg/dL) | 163 ± 24.5 | 166 ± 41.6 | 0.849 |
 Zinc (µg/dL) | 64 ± 11.2 | 64 ± 14.7 | 0.950 |